| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-15 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |